279 related articles for article (PubMed ID: 32299111)
41. Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.
Keil MF; Stratakis CA
Expert Rev Neurother; 2008 Apr; 8(4):563-74. PubMed ID: 18416659
[TBL] [Abstract][Full Text] [Related]
42. Familial isolated pituitary adenomas: an emerging clinical entity.
Martucci F; Trivellin G; Korbonits M
J Endocrinol Invest; 2012 Dec; 35(11):1003-14. PubMed ID: 23310926
[TBL] [Abstract][Full Text] [Related]
43. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
Vasilev V; Daly AF; Trivellin G; Stratakis CA; Zacharieva S; Beckers A
Endocr Relat Cancer; 2020 Aug; 27(8):T77-T86. PubMed ID: 32083999
[TBL] [Abstract][Full Text] [Related]
44. Molecular genetics of the aip gene in familial pituitary tumorigenesis.
Tahir A; Chahal HS; Korbonits M
Prog Brain Res; 2010; 182():229-53. PubMed ID: 20541668
[TBL] [Abstract][Full Text] [Related]
45. Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications.
Jaffrain-Rea ML; Daly AF; Angelini M; Petrossians P; Bours V; Beckers A
Expert Rev Endocrinol Metab; 2011 Mar; 6(2):195-214. PubMed ID: 30290451
[TBL] [Abstract][Full Text] [Related]
46. [Familial pituitary adenomas].
Burlacu MC; Tichomirowa M; Daly A; Beckers A
Presse Med; 2009 Jan; 38(1):112-6. PubMed ID: 18990538
[TBL] [Abstract][Full Text] [Related]
47. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
48. The genetics of pituitary adenomas.
Vandeva S; Jaffrain-Rea ML; Daly AF; Tichomirowa M; Zacharieva S; Beckers A
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):461-76. PubMed ID: 20833337
[TBL] [Abstract][Full Text] [Related]
49. Overview of genetic testing in patients with pituitary adenomas.
Beckers A; Rostomyan L; Daly AF
Ann Endocrinol (Paris); 2012 Apr; 73(2):62-4. PubMed ID: 22503805
[TBL] [Abstract][Full Text] [Related]
50. [Rare forms of hereditary endocrine neoplasia: co-existence of pituitary adenoma and pheochromocytoma/paraganglioma].
Mamedova EO; Lisina DV; Belaya ZE
Probl Endokrinol (Mosk); 2023 May; 69(2):24-30. PubMed ID: 37448268
[TBL] [Abstract][Full Text] [Related]
51. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
[TBL] [Abstract][Full Text] [Related]
52. Characteristics of familial isolated pituitary adenomas.
Daly AF; Vanbellinghen JF; Beckers A
Expert Rev Endocrinol Metab; 2007 Nov; 2(6):725-733. PubMed ID: 30290472
[TBL] [Abstract][Full Text] [Related]
53. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
Rostomyan L; Daly AF; Petrossians P; Nachev E; Lila AR; Lecoq AL; Lecumberri B; Trivellin G; Salvatori R; Moraitis AG; Holdaway I; Kranenburg-van Klaveren DJ; Chiara Zatelli M; Palacios N; Nozieres C; Zacharin M; Ebeling T; Ojaniemi M; Rozhinskaya L; Verrua E; Jaffrain-Rea ML; Filipponi S; Gusakova D; Pronin V; Bertherat J; Belaya Z; Ilovayskaya I; Sahnoun-Fathallah M; Sievers C; Stalla GK; Castermans E; Caberg JH; Sorkina E; Auriemma RS; Mittal S; Kareva M; Lysy PA; Emy P; De Menis E; Choong CS; Mantovani G; Bours V; De Herder W; Brue T; Barlier A; Neggers SJ; Zacharieva S; Chanson P; Shah NS; Stratakis CA; Naves LA; Beckers A
Endocr Relat Cancer; 2015 Oct; 22(5):745-57. PubMed ID: 26187128
[TBL] [Abstract][Full Text] [Related]
54. [Clinical and genetic characterization of FIPA (familial isolated pituitary adenomas)].
Beckers A; Apetrii P; Daly A; Tichomirova M; Vanbellingen JF; Georges M; Bours V
Rev Med Liege; 2009; 64 Spec No():15-9. PubMed ID: 20085010
[TBL] [Abstract][Full Text] [Related]
55. Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors.
Horvath A; Stratakis CA
Rev Endocr Metab Disord; 2008 Mar; 9(1):1-11. PubMed ID: 18200440
[TBL] [Abstract][Full Text] [Related]
56. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
Karhu A; Aaltonen LA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
[TBL] [Abstract][Full Text] [Related]
57. Genetics of gigantism and acromegaly.
Hannah-Shmouni F; Trivellin G; Stratakis CA
Growth Horm IGF Res; 2016; 30-31():37-41. PubMed ID: 27657986
[TBL] [Abstract][Full Text] [Related]
58. Familial pituitary tumor syndromes.
Elston MS; McDonald KL; Clifton-Bligh RJ; Robinson BG
Nat Rev Endocrinol; 2009 Aug; 5(8):453-61. PubMed ID: 19564887
[TBL] [Abstract][Full Text] [Related]
59. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis.
Poncin J; Stevenaert A; Beckers A
Eur J Endocrinol; 1999 Jun; 140(6):573-6. PubMed ID: 10366412
[TBL] [Abstract][Full Text] [Related]
60. Clinical and genetic features of familial pituitary adenomas.
Daly AF; Jaffrain-Rea ML; Beckers A
Horm Metab Res; 2005 Jun; 37(6):347-54. PubMed ID: 16001326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
